Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

75%

3 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 4
3(75.0%)
N/A
1(25.0%)
4Total
Phase 4(3)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05011838Not ApplicableWithdrawn

Evaluation of the Effectiveness of an Intervention to Reduce Gaps in Hypertension Care in Low-income Medellin, Colombia

Role: collaborator

NCT02839421Phase 4Unknown

Efficacy of Three Antibiotic Protocols for Aggressive Periodontitis Treatment

Role: lead

NCT02125812Phase 4Completed

Adjunctive Systemic Administration of Moxifloxacin in the Treatment of Aggressive Periodontitis

Role: lead

NCT00805558Phase 4Completed

Comparison of Moxifloxacin With Ciprofloxacin/Metronidazole on Patients With Chronic Periodontitis

Role: lead

All 4 trials loaded